Evidence map›Paper›PMID 42009790›Full record

ArticleScientific reports2026

Mixed reality navigation system for ultrasound-guided and fusion biopsies using markerless instrument tracking.

Michal Trojak, Maciej Stanuch, Andrzej Skalski

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Michal TrojakAGH University of Krakow, Krakow, PL30059, Poland.
Maciej StanuchMedApp S.A., Krakow, PL30037, Poland.
Andrzej SkalskiAGH University of Krakow, Krakow, PL30059, Poland. skalski@agh.edu.pl.

Funding

Ministry of Science and Higher Education, Poland DWD/6/0235/2022
6 · The paper itself

Abstract

Percutaneous needle biopsy is commonly performed under ultrasound guidance to visualize the target lesion and monitor needle position. This study aims to improve spatial information for the operator by accurately visualizing the ultrasound image at its true anatomical location and scale within a head-mounted display, co-registered with pre-procedural imaging data. Current mixed reality systems rely on fiducial markers to track the instruments, which limits their practical utility in clinical settings; therefore, this study evaluated a custom markerless method for ultrasound probe tracking that achieved accuracy suitable for clinical applications. By displaying the ultrasound image relative to the probe's spatial position, the system enables seamless fusion with pre-procedural imaging data. Combined with markerless needle tracking, this approach provides a complete navigation solution. Target registration error analysis between 2D ultrasound and 3D computed tomography demonstrated a 95% likelihood that the error remains within 3.41 mm. A biopsy navigation assessment test confirmed the system's strong potential to reduce the number of puncture attempts compared to conventional ultrasound guidance alone. By providing comprehensive spatial and imaging information, the navigation system may contribute to reduced operator error and improved procedural success rates.

Indexed as

Augmented RealityImage-Guided BiopsyUltrasonography, InterventionalBiopsy, NeedleHumansImaging, Three-DimensionalTomography, X-Ray ComputedUltrasonographyAugmented RealityBiopsyComputer VisionLocatable UltrasoundMixed RealitySurgical Navigation

Identifiers

PMID42009790
PMCPMC13260812

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.